Holen Sie sich die Stockscreener-App
630.56
1.88%
-12.06
Handel nachbörslich:
632.00
1.44
+0.23%
Schlusskurs vom Vortag:
$642.62
Offen:
$638.355
24-Stunden-Volumen:
30.81M
Relative Volume:
1.37
Marktkapitalisierung:
$1.61T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
22.92
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
-10.61%
1M Leistung:
-16.11%
6M Leistung:
-6.59%
1J Leistung:
-14.60%
1-Tages-Spanne:
$627.80
$647.69
1-Wochen-Bereich:
$627.80
$713.22
52-Wochen-Spanne:
$520.26
$779.82
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, RDDT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
630.56 | 1.61T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
316.80 | 3.87T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
314.19 | 3.84T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
572.36 | 117.67B | 20.32B | 3.16B | 3.82B | 12.55 |
RDDT
Reddit Inc
|
138.45 | 26.64B | 2.47B | 707.54M | 868.73M | 3.5267 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-09-25 | Bestätigt | Canaccord Genuity | Buy |
| 2026-09-25 | Bestätigt | Deutsche Bank | Buy |
| 2026-09-25 | Bestätigt | Piper Sandler | Overweight |
| 2026-09-25 | Bestätigt | TD Cowen | Buy |
| 2026-09-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-09-21 | Bestätigt | Wells Fargo | Overweight |
| 2026-09-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2026-08-27 | Bestätigt | Rosenblatt | Buy |
| 2026-08-27 | Bestätigt | Truist | Buy |
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Meta Reported a Great Quarter and the Stock Still Fell. Is It a Buy? - The Motley Fool
Vanguard's Growth ETF Usually Beats the Market After a Lagging Year. I'd Own It, but Not for a 2027 Rebound. - The Motley Fool
Stock Market Today, Oct. 26: AI Optimism Lifts Nasdaq as Tech Stocks Rebound - The Motley Fool
Is CoreWeave a Screaming Buy Right Now? 3 Reasons the Stock Could Hit $100 Before the End of the Year. - The Motley Fool
Anthropic's IPO Keeps Founders in Control Through a "Founder LLC" Voting Structure - The Motley Fool
1 Reason to Buy Meta Stock Now and Hold for the Long Term - The Motley Fool
News Failure: Neocloud Stocks Defy Musk's Warning - Zacks Investment Research
RDDT Rides on Strong Demand in Ad Business: Can It Beat META and SNAP? - Zacks Investment Research
Not AMD. Not Marvell. Here's Which Company Nvidia Needs to Be Worried About. - The Motley Fool
Warren Buffett's Favorite Stock Market Indicator Is Flashing Red. Here's What History Warns Is Coming Next. - The Motley Fool
Meta Stock Has Dropped the Day After 3 Straight Earnings Reports. Is It a Buy Now? - The Motley Fool
Micron Just Delivered a Monster Quarter, but the Stock Is Plummeting. The Reason Is Obvious. - The Motley Fool
1 Unstoppable Stock-Split Stock to Buy Before It Joins Nvidia, Alphabet, Microsoft, and Apple in the $3 Trillion Club - The Motley Fool
Meta Platforms, Inc. (META) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
Breakfast News: Science Strikes Back at Cancer - The Motley Fool
Software ETFs: Hidden Gems Amid the AI Selloff? - Zacks Investment Research
Prediction: Broadcom Will Be a $4.5 Trillion Company by 2030 - The Motley Fool
Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar? - Zacks Investment Research
Wall Street's Blockbuster Stock Split Was Just Announced, and It's Anything but Conventional - The Motley Fool
The Nasdaq Composite Just Plunged Almost 700 Points in One Day: Is a Stock Market Crash Imminent? - The Motley Fool
Down 17%, Is Meta a Buy on the Dip? - The Motley Fool
Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - GlobeNewswire Inc.
Not Nvidia. Not Microsoft. This "Magnificent Seven" Stock Is the Cheapest Right Now. - The Motley Fool
Breakfast News: The Sunday Edition - The Motley Fool
If the Stock Market Crashes, This Is the First ETF I'm Loading Up On - The Motley Fool
SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America) - GlobeNewswire Inc.
Alphabet's 2 Classes of Common Stock Trade About 1% Apart. Here's the One I'd Buy. - The Motley Fool
Before You Buy the Vanguard S&P 500 ETF, There's 1 Sneaky Risk Investors Should Know - The Motley Fool
The Nasdaq Just Had Its Worst Day in 4 Months. Here's the Level That Would Signal a Correction, and What History Says Investors Can Do About It. - The Motley Fool
Broadcom vs. Dell Technologies: Which Stock Is AI Powering to Be a Better Buy in 2026? - The Motley Fool
AI-119 Vulcan Force Solution Targets California's May 2027 Frontier AI Deadline (Veterans First for America) - GlobeNewswire Inc.
Prediction: 2 Stocks That Will Be Worth More Than IonQ 5 Years From Now - The Motley Fool
The Puzzle Pieces for a Stock Market Crash Are Taking Shape, With 4 Historically Flawless Indicators Now Sounding the Alarm - The Motley Fool
Billionaire Ken Griffin Says We May Be in a Bubble. Here’s What History Says Happens Next. - The Motley Fool
Here's the AI Chip Stock That Hedge Funds Are Loading Up On - The Motley Fool
OpenAI Nears $1.25 Trillion Valuation. What That Tells Investors Ahead of a Potential 2027 IPO. - The Motley Fool
CoreWeave Is Down 13% in a Week. Here's the Price at Which I'd Buy - The Motley Fool
Q3 Earnings Season: Strong Base, Higher Revision Trends, and Promising 2027 Outlook - Zacks Investment Research
Not Intel. Not CoreWeave. This Underappreciated Nvidia-Backed Company Is Growing Artificial Intelligence (AI) Revenue by 123%. Here's Why It's a Buy Today for $8. - The Motley Fool
Facing Investing Fears - The Motley Fool
Constellation Energy vs. GE Vernova: Which Utilities Stock Is a Better Buy in 2026? - The Motley Fool
U.S. Stock Futures Fall on AI Trade Concerns - Zacks Investment Research
Pre-Markets Remain Spooked by AI Investment Capacity - Zacks Investment Research
Breakfast News: Week in Review - The Motley Fool
ETFs in Focus as META Drops 7% Despite Q3 Earnings Beat, Strong View - Zacks Investment Research
Is Meta Platforms Stock a Buy as Revenue Continues to Soar? - The Motley Fool
If a Stock Market Crash Is on the Way, Warren Buffett Says This Is the Best Thing Investors Can Do for Their Portfolio - The Motley Fool
Stock Market News for Oct 23, 2026 - Zacks Investment Research
Meta Is Doing Something It’s Never Done Before. Here’s What It Means for Investors. - The Motley Fool
Zacks Investment Ideas feature highlights: Meta Platforms and Pepsi - Zacks Investment Research
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Officer |
Oct 26 '26 |
Proposed Sale |
640.00 |
1,575 |
1,008,000 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 19 '26 |
Sale |
707.20 |
629 |
444,829 |
947 |
| Olivan Javier | Chief Operating Officer |
Oct 19 '26 |
Sale |
707.20 |
946 |
669,011 |
5,986 |
| Olivan Javier | Officer |
Oct 19 '26 |
Proposed Sale |
707.20 |
1,575 |
1,113,840 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 12 '26 |
Sale |
728.10 |
946 |
688,783 |
6,932 |
| Olivan Javier | Chief Operating Officer |
Oct 12 '26 |
Sale |
728.10 |
629 |
457,975 |
1,004 |
| Olivan Javier | Officer |
Oct 12 '26 |
Proposed Sale |
728.10 |
1,575 |
1,146,757 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
629 |
457,962 |
1,061 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
946 |
688,764 |
7,878 |
| Olivan Javier | Officer |
Oct 05 '26 |
Proposed Sale |
728.08 |
1,575 |
1,146,726 |
0 |
2.03%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):